| |
|
|
|
Immunogen Inc
|
|
6.10 -0.32 (-4.98%) |
10/19/2017 10:33am |
|
Open: |
6.35 |
Pre close: |
6.42 |
Target:
|
8.57
|
|
High: |
6.47 |
Low: |
6.08 |
Resistance:
|
7.34
8.28
|
|
Volume: |
927,183 |
Market Cap: |
546.54M |
Support:
|
5.81
4.83
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.15
 |
MACD |
MACD(12,26):
|
-0.21  |
|
MA(20): |
6.85 |
Signal(12,26,9): |
-0.10 |
|
MA(100): |
6.37 |
Stochastic Oscillator |
%K(14,3):
|
18.35 |
|
MA(250): |
4.29 |
%D(3): |
14.71 |
|
Average Volume(K) |
3-Month: |
357339
|
52-Week |
High:
|
8.84 |
|
10-Days: |
297919 |
Low: |
1.51 |
|
RSI |
RSI(14):
|
41.73 |
Change(%): |
171.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.220 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-0.730 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
83.35 |
|
EPS Est. Next Year |
-1.450 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.03 |
|
EPS Est. Next Quarter |
-0.230 |
Qtrly Rev. Growth |
426.7 |
% Held by Institutions |
87.89 |
|
Forward EPS |
-1.530 |
Gross Profit (p.s.) |
0.535 |
Shares Short (K) |
17450 |
|
Book Value (p.s.) |
-1.930 |
EBITDA (p.s.) |
-0.619 |
P/E |
-5.07 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-3.20 |
|
Profit Margin |
-127.24 |
Operating Cash Flow
(M) |
-117.21 |
P/S |
722416256.00 |
|
Operating Margin |
-90.63 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
-0.00 |
|
|
|
|
|
|
|
